:: SIHL ::

Company Profile

Smart Quotes

AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo

BSE1109.6559.3 (+5.65 %)

PREV CLOSE ( ) 1050.35

OPEN PRICE ( ) 1060.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 376916

TODAY'S LOW / HIGH ( )1060.05 1118.00

52 WK LOW / HIGH ( )994.35 1592.55

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 26-12 1986

Management Info

Mangalam Ramasubramanian Kumar - Chairman K Nityananda Reddy - Managing Director

Registered Office

Address Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone 040-23736370 / 23747340

Email info@aurobindo.com

Website www.aurobindo.com

Registrar's Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

06Sep USFDA completes inspection at Aurobind
The United States Food and Drug Administration (USFDA) has inspected Aur..

30Aug USFDA completes inspection at Aurobind
The United States Food and Drug Administration (USFDA) has inspected Uni..

26Aug Aurobindo Pharma’s arm obtains marketi
Aurobindo Pharma’s wholly owned step-down subsidiary -- CuraTeQ Biologic..

26Aug Aurobindo Pharma informs about disclos
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..

20Aug Aurobindo Pharma informs about press r
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..

Financials

in Crores

	QTR Jun 25	ANNUAL 25
Net Profit	559.13	1746.79
Gross Profit	750.09	2358.45
Operating Profit	880.11	2885.69
Net Sales	2848.17	10933.3

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE) 15560.90 (5.25%)	M.Cap ( in Cr)19964.46
Astrazeneca Pharma I (BSE) 9065.70 (0.90%)	M.Cap ( in Cr)22664.25
Alkem Laboratories (BSE) 5397.40 (1.44%)	M.Cap ( in Cr)64534.01
Gland Pharma (BSE) 1965.55 (3.27%)	M.Cap ( in Cr)32383.70
Haleos Labs (BSE) 1206.20 (4.59%)	M.Cap ( in Cr)364.67

Shareholding Pattern

	PROMOTERS	51.82%
	MUTUAL FUNDS/UTI	18.96%
	NON-INSTITUTION	6.87%
	FI/BANKS/INSURANCE	5.49%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Quant Manufacturing Fund-Reg(G)	8.09
Quant Mid Cap Fund(G)	7.41
Mirae Asset Healthcare Fund-Reg(G)	6.67
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)	6.06
Quant Large & Mid Cap Fund(G)	5.89
Quant Healthcare Fund-Reg(G)	5.80
Tata India Pharma & Healthcare Fund-Reg(G)	5.44

SIHL House, Opp.Ambawadi Jain Temple, Nehrunagar Cross Roads, Ahmedabad-380015

Prevent Unauthorised transactions in your account. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge as well as for mobile no and for email id updation.Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month........... Issued in the interest of Investors".

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account

REGISTRATION NO

SEBI Regn.no. INZ000167335 Member Code: NSE - 07590, BSE Sebi Regn. 943, MCX - 57480 APRN CODE: APRN06051, AMFI ARN: 39843 SEBI Registration No. (DP)- IN-DP-465-2020 NSDL:IN-DP-NSDL-34-97,DP ID:IN300343 CDSL:IN-DP-CSDL-199-2003,DP ID:12029300 Approved person Registration no. with NSDL Database Management Limited(NDML) :IRDA/IR1/2013/004Approved person Registration no. with Center Insurance Repository Limited (CIR): IRDA/IR2/2013/123

REGISTERED ADDRESS:

810, X-Change Plaza, DSCCSL (53E), Road 5E, Block 53, Zone 5, Gift City, Gandhinagar 382050

SHAH INVESTOR'S HOME LTD. CIN NO:-U67120GJ1994PLC023257 SIHL COMMODITIES LTD. CIN NO:-U45201GJ1995PLC025825SIHL CONSULTANCY LTD. CIN NO:-U74140GJ2006PLC049662 SIHL FINCAP LTD.CIN NO:-U65923GJ2006PLC049661 SIHL GLOBAL INVESTMENTS (IFSC) PVT. LTD. CIN NO:-U67190GJ2016PTC094444NSEL MemberCode :10560

CORRESPONDENCE ADDRESS:

SIHL House, Opp. Ambawadi Jain Temple, Nehrunagar Cross Road, Ahmedabad-380015.

For any complains email us at investors@sihl.in Shah Investor's Home Ltd. Member: